Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Technology Applied for Molecular Testing Outside of Central Laboratories

By LabMedica International staff writers
Posted on 16 Apr 2012
A collaborative program has been initiated to develop assays utilizing the new Discipher system for bringing DNA-based testing and diagnostics to point-of-care settings.

Discipher is a low cost, walk-away system, based on DVD technology. More...
It uses self-contained, disposable assay devices in the form of DVD discs with microfluidic channels. The system was jointly developed by UK-based scientific engineering company Plarion Ltd. (Hertfordshire, UK) and the Scandinavian diagnostics technology development company LingVitae Corporation (Oslo, Norway). This work was supported by funding from the Seventh Research Framework Program of the European Union, under the Digital Sequencing project.

The new research and development collaboration will bring in the Sweden-based technical university KTH Royal Institute of Technology (KTH; Stockholm, Sweden). As part of this engagement, LingVitae/Plarion will transfer prototype versions of the Discipher instrument to the researchers at KTH, as well as support the development work by customizing the optical disc-based disposable assay devices.

“Our aim with Discipher is to democratize molecular and cellular analysis, putting low-cost easy-to-use tools in the hands of the wider community, outside of core laboratories”, said Dr. Jackie Cole, Head of Marketing for Plarion. “We see that the Discipher system addresses an unmet need in bringing DNA-based diagnostics and testing to users who have previously not had access to this technology,” says Prof. Lundeberg, based at the Science for Life Laboratory in Stockholm.

Dr. Preben Lexow, Chief Executive Officer of LingVitae, added, “We look forward to the collaboration with Professor Lundeberg’s group [at KTH]. The track-record of KTH on development of DNA-based assays, utilizing a repertoire of molecular techniques, provides an exciting opportunity for us to expand our activities in the DNA assay space.”

The innovative Discipher system - with its integrated temperature control, centrifuge, and high-resolution readout - is well suited for point-of-care assays requiring minimal end user operation, rapid turnaround times, and ability to multiplex tests. Assay developers, especially in the areas of immune and cellular assays, are encouraged to contact LingVitae to discuss collaborations or assay transfers to the Discipher system.

Related Links:

KTH Royal Institute of Technology
LingVitae Corporation
Plarion Ltd.




New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The cell-based tests bring artificial intelligence to transplant outcome care (Photo courtesy of iStock)

AI-Enhanced Cell-Based Blood Tests to Improve Predictive Accuracy for Complex Transplant Outcomes

Managing immunosuppressive drugs in transplant patients is a delicate challenge. Insufficient medication can lead to rejection, which may be cell- or antibody-mediated, while excess immunosuppression raises... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: A saliva test can help predict future metabolic health concerns including diabetes and obesity (Photo courtesy of 123RF)

Saliva Test to Enable Early Detection of Diabetes and Obesity

Type 2 diabetes affects about 400 million people globally and is typically diagnosed through elevated blood glucose levels. However, conditions like insulin resistance and hyperinsulinemia may begin developing... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.